![Foto de Ascensión](/img/nophoto.png)
Ascensión
López Díaz de Cerio
Publications dans lesquelles il/elle collabore avec Ascensión López Díaz de Cerio (6)
2020
-
Maintenance therapy with ex vivo expanded lymphokine-activated killer cells and rituximab in patients with follicular lymphoma is safe and may delay disease progression
British Journal of Haematology, Vol. 189, Núm. 6, pp. 1064-1073
2016
-
Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activity
Immunologic Research, Vol. 64, Núm. 2, pp. 548-557
2006
-
Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma
Journal of the National Cancer Institute, Vol. 98, Núm. 18, pp. 1292-1301
2004
-
Past, present and future of anti-idiotype vaccination
Revista de medicina de la Universidad de Navarra, Vol. 48, Núm. 3, pp. 14-23
2003
-
Estrategias terapéuticas con vacunas idiotípicas en el tratamiento del linfoma folicular
Hematologia - Citocinas, Inmunoterapia y Terapia Celular, Vol. 6, Núm. 3, pp. 175-182
-
Feasibility of idiotype vaccination in relapsed B-cell malignancies
Haematologica, Vol. 88, Núm. 12, pp. 1438-1440